On 8th March 2019 ASCIA (Australasian Society of Clinical Immunology and Allergy) hosted a meeting in Melbourne to develop a National Immunodeficiency Strategy. The mission is to improve the health and wellbeing of people with primary immunodeficiencies (PIDs) and minimise the impact on individuals, carers, health services and the community.
Delegates from across Australia and New Zealand included clinical immunology specialists, nurses and dietitians (ASCIA members), patient organisations (AusPIPS, IDFA, IDFNZ, HAE Australasia), major research centres (JMF Melbourne, ANU, WEHI, Garvan), funding bodies (National Blood Authority and Jurisdictional Blood Committee), supply channels (Australian Red Cross Blood Service) and other potential collaborators such as NBS MedicineWise. The meeting was supported by unrestricted educational grants from CSL Behring and Grifols. The program and outcomes are not influenced by this support.